AMPH
$40.17
Revenue | $178.11Mn |
Net Profits | $36.17Mn |
Net Profit Margins | 20.31% |
PE Ratio | 15.73 |
Amphastar Pharmaceuticals Inc’s revenue jumped 31.91% since last year same period to $178.11Mn in the Q4 2023. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated -1.36% fall in its revenue since last 3-months.
Amphastar Pharmaceuticals Inc’s net profit jumped 6.65% since last year same period to $36.17Mn in the Q4 2023. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated -26.52% fall in its net profits since last 3-months.
Amphastar Pharmaceuticals Inc’s net profit margin fell -19.15% since last year same period to 20.31% in the Q4 2023. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated -25.51% fall in its net profit margins since last 3-months.
Amphastar Pharmaceuticals Inc’s price-to-earnings ratio after this Q4 2023 earnings stands at 15.73.
EPS Estimate Current Quarter | 0.78 |
EPS Estimate Current Year | 0.78 |
Amphastar Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.78 - a -16.13% fall from last quarter’s estimates.
Amphastar Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.78.
Earning Per Share (EPS) | 0.88 |
Return on Assets (ROA) | 0.11 |
Return on Equity (ROE) | 0.24 |
Amphastar Pharmaceuticals Inc’s earning per share (EPS) jumped 20.55% since last year same period to 0.88 in the Q4 2023. This indicates that the Amphastar Pharmaceuticals Inc has generated 20.55% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Amphastar Pharmaceuticals Inc’s return on assets (ROA) stands at 0.11.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Amphastar Pharmaceuticals Inc’s return on equity (ROE) stands at 0.24.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-02-29 | 0.93 | 0.88 | -5.38% |
2023-08-09 | 0.56 | 0.65 | 16.07% |
2023-05-09 | 0.48 | 0.62 | 29.17% |
2023-11-08 | 0.69 | 1.15 | 66.67% |